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Abstract
Background: A major boost to the cystic fibrosis disease research was given by the generation of
various mouse models using gene targeting in embryonal stem cells. Moreover, the introduction of
the same mutation on different inbred strains generating congenic strains facilitated the search for
modifier genes. From the original CftrTgH(neoim)Hgu CF mouse model we have generated using strict
brother × sister mating two inbred CftrTgH(neoim)Hgu mouse lines (CF/1 and CF/3). Thereafter, the
insertional mutation was introgressed from CF/3 into three inbred backgrounds (C57BL/6, BALB/
c, DBA/2J) generating congenic animals. In every backcross cycle germline transmission of the
insertional mutation was monitored by direct probing the insertion via Southern RFLP. In order to
bypass this time consuming procedure we devised an alternative PCR based protocol whereby
mouse strains are differentiated at the Cftr locus by Cftr intragenic microsatellite genotypes that are
tightly linked to the disrupted locus.
Results: Using this method we were able to identify animals carrying the insertional mutation
based upon the differential haplotypic backgrounds of the three inbred strains and the mutant
CftrTgH(neoim)Hgu at the Cftr locus. Moreover, this method facilitated the identification of the precise
vector excision from the disrupted Cftr locus in two out of 57 typed animals. This reversion to wild
type status took place without any loss of sequence revealing the instability of insertional mutations
during the production of congenic animals.
Conclusions: We present intragenic microsatellite markers as a tool for fast and efficient
identification of the introgressed locus of interest in the recipient strain during congenic animal
breeding. Moreover, the same genotyping method allowed the identification of a vector excision
event, posing questions on the stability of insertional mutations in mice.
Background
Cystic fibrosis (CF) is a common and fatal recessive dis-
ease, which is caused by dysfunction of a chloride chan-
nel, termed the CF transmembrane conductance regulator
(CFTR). Since the isolation of the murine homologue of
the human CFTR gene on Chromosome 6 [1] several
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two different categories; those designed to mimic clinical
human mutations such as the F508del [2-4], G551D [5]
and G480C [6], and those with a disrupted Cftr gene
resulting in either no or reduced production of CFTR.
Although most mouse models share phenotypic charac-
teristics, particularly, the most CF-like severe pathology is
observed in the gastrointestinal tract, important variations
in phenotype have been observed which may relate to the
specific mutation and the genetic background of the tar-
geted strain. Studies using Cftr knockout mice demon-
strated differential severity of airway [7] and intestinal [8]
disease. Candidate modulators for growth, airway and
intestinal disease have been mapped to loci on chromo-
somes 1, 6, 7, 10 and 13 [9]; 1, 2, 10 and 17 [10]; 3 and 5
[11], respectively.
Dorin et al. [12] established a CF mutant mouse
CftrTgH(neoim)Hgu, using an insertional gene targeting vector
to disrupt exon 10 of the Cftr gene in 129P2 embryonic
stem cells. This targeted mutation was made by inser-
tional mutagenesis using a fragment of DNA containing
intron 9 and part of exon 10 (Figure 1). The mutation is
slightly "leaky", in that low levels of wild type Cftr mRNA
are produced as a result of exon skipping and aberrant
splicing [13], but these mutant mice nevertheless dis-
played the electrophysiological defect in the gastrointesti-
nal and respiratory tract which is characteristic of CF [14].
We have generated two different inbred lines named CF/
1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu using brother-
sister mating for more that 26 generations. In order to test
whether the genetic background of the CftrTgH(neoim)Hgu
mouse influences the development of the phenotype, we
introgressed the mutation from the CF/3- CftrTgH(neoim)Hgu
into three different inbred strains (C57BL/6, BALB/c,
DBA/2J) generating B6.129P2(CF/3)- CftrTgH(neoim)Hgu,
C.129P2(CF/3)-CftrTgH(neoim)Hgu, D2.129P2(CF/3)-
CftrTgH(neoim)Hgu congenic mice. During backcrossing the
targeted mutation was determined by Southern RFLP
analysis of XbaI/SalI genomic digests with probe 1.2H
(Figure 1) as outlined in the original report [12]. Here we
describe an alternative genotyping technique utilising
informative Cftr intragenic microsatellite markers in order
to follow germline transmission of the mutated Cftr locus
in the three inbred backgrounds. The four markers span-
ning 101 kb of the Cftr gene allowed straight forward dif-
ferentiation between the two inbred CF strains and the
three inbred wild type strains by microsatellite haplotype.
Southern and microsatellite mutation genotypes were
confirmed in 55 of 57 typed mice. In two cases, however,
the insertion mutation status deduced from Southern
hybridisation and microsatellite genotypes did not match.
Further mapping and sequencing revealed that the 7.3 kb
insertion vector had been excised from the Cftr locus. This
spontaneous reversion to wild type sheds serious doubts
for the stability of insertion mutations in heterozygous
mice.
Results
From the original CftrTgH(neoim)Hgu mutant mouse gener-
ated using insertional mutagenesis in the Cftr exon 10
[12] we have established two inbred CF strains CF/1-
CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu by strict brother
sister mating. We have generated three inbred congenic
strains by backcrossing the targeted mutation to three dif-
ferent inbred backgrounds C57BL/6, DBA/2J and BALB/c.
To observe germline transmission of the mutation after
each backcross and after the first incross to develop
homozygous congenic strains, mice were genotyped using
Southern Blot Hybridisation to indicate the transmission
of the insertional vector pIV3.5H (Figure 1). Since South-
ern analysis is cumbersome and time consuming, we
devised an alternative protocol for genotyping, whereby
animals are differentiated at the Cftr locus by intragenic
microsatellite genotypes tightly linked with the intron 9
and exon 10 of Cftr chosen for insertion mutagenesis in
the CftrTgH(neoim)Hgu mouse mutant.
Allele distribution between the strains. Consistent 
genotyping
Four of the six tested Cftr intragenic microsatellite markers
(D6NC3, D6NC2, D6Mit236 and D6NC5) allowed the
discrimination of the three inbred strains (C57BL/6,
BALB/c, DBA/2J) from the two inbred CF strains CF/1-
CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu (Figure 2). The
two inbred CF/1-CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu
lines shared the same marker alleles in all four informa-
tive microsatellites being distinct from the three inbred
strains. (Figure 2). Hence, a mouse homozygous for the
disrupted locus can be identified by the genotype:
D6NC3:20/20, D6NC2:20/20, D6Mit236: 20/20,
D6NC5: 20/20. Accordingly, the representative genotypes
of a a) wild type BALB/c animal will be (D6NC3: 16/16,
D6NC2: 13/13, D6Mit236: 31/31, D6NC5: 30/30); b)
wild type C57BL/6 (D6NC3: 14/14, D6NC2: 15/15,
D6Mit236: 35/35, D6NC5: 21/21); c) wild type DBA/
2J(D6NC3: 16/16, D6NC2: 13/13, D6Mit236: 44/44,
D6NC5: 32/32).
In order to determine whether germline transmission of
the mutation can be accurately assessed via the haplotype
of the informative intragenic microsatellites linked to the
disrupted Cftr locus, we tested all three congenic strains.
Fifty-seven animals (C.129P2(CF/3)-CftrTgH(neoim)Hgu n =
31, B6.129P2(CF/3)- CftrTgH(neoim)Hgu n = 9 and
D2.129P2(CF/3)-CftrTgH(neoim)Hgu n = 17) selected at ran-
dom at generation N10F2 and N10F3 from both hetero-
zygous and homozygous CF matings were compared in
the 1.2H probe restriction XbaI/SalI RFLP and marker gen-
otypes of the three informative intragenic Cftr microsatel-Page 2 of 12
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BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/6Generation of the CftrTgH(neoim)Hgu mouse modelFigure 1
Generation of the CftrTgH(neoim)Hgu mouse model. a) Insertional disruption of the murine Cftr gene and predicted gene 
structure as described by Dorin et al. (1992). Abbreviations: S, SalI; H, HindIII; X, XbaI. Map position of the CFneo1 and 
CFneo2 products is also indicated. b) Genotype analysis of heterozygous cf/+ matings. The probe 1.2H issued in order to iden-
tify via Southern hybridisation the congenic mice which carry the insertion. DNAs were digested with XbaI+SalI and probed 
with 1.2H. The upper hybridising fragment of 6.6 Kb represents the wild type allele, the lower 5 Kb fragment is diagnostic for 
the insertional mutation.
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BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/6Microsatellite genotypingFigure 2
Microsatellite genotyping. a) Localisation of the intragenic polymorphisms on the physical map of the murine Cftr gene. b) 
Analysis of the four informative intragenic microsatellites by direct blotting electrophoresis. c) Microsatellite alleles were 
ascertained by arbitary repeat units. The alleles for all four microsatellites which are representative of the two CF inbred lines 
(CF/1 and CF/3)and hence directly linked with the disease causing allele carrying the insertional vector pIV3.5H in Cftr exon 10 
have been given the number 20.
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BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/6lites (D6NC3 intron1, D6Mit236 intron 9, D6NC5 intron
18) equally distributed along the Cftr gene. Southern
RFLP and microsatellite marker genotypes were authenti-
cated for 55 mice. Absence and presence of the insertional
mutation in intron 9/exon 10 in homozygous or hetero-
zygous mice could be clearly deduced from the microsat-
ellite genotypes (Figure 2 – Table 1).
Excision of the pIV3.5H vector
In two out of the 57 investigated animals the mutant gen-
otypes as defined by Southern and microsatellite geno-
types were discordant (Table 2). In detail, mouse A was
classified heterozygous CF by Southern and homozygous
CF by the microsatellites and mouse B homozygous wild
type by Southern and homozygous CF by the microsatel-
lites. Genotyping via Southern Blot Hybridization indi-
cates and depends upon the existence or absence of the
insertional vector pIV3.5H designed to disrupt the Cftr
gene in exon 10. Therefore, as a first step we tried to verify
the presence or absence of the pIV3.5H vector with a
straight forward PCR assay that scans the ends of the het-
erologous vector sequence (Figure 1). One PCR product
scans the junctions between intron 9 and the inserted
plasmid sequence, the other PCR product the junction
between the neo gene and the endogenous intron 9
encompassing the unique SalI site. The results of the PCR
assays were consistent with the Southern data i.e. for
mouse A both insert specific products were present indi-
cating an intact vector on one chromosome, whereas for
mouse B both products were absent. This data strongly
suggests that the pIV3.5H insertion vector had been
excised from the CF/3- CftrTgH(neoim)Hgu Cftr locus at least in
mouse B.
Table 1: Expected Southern and microsatellite genotypes for animals backcrossed to the three inbred backgrounds.
1,2H D6NC3 D6Mit236 D6NC5
BALB/c
n/n 16/16 31/31 30/30 Homozygote wt
cf/n 16/20 31/20 30/20 Heterozygote mt
cf/cf 20/20 20/20 20/20 Homozygote mt
C57BL/6
n/n 14/14 35/35 21/21 Homozygote wt
cf/n 20/14 20/35 20/31 Heterozygote mt
cf/cf 20/20 20/20 20/20 Homozygote mt
DBA/2J
n/n 16/16 44/44 32/32 Homozygote wt
cf/n 20/16 20/44 20/32 Heterozygote mt
cf/cf 20/20 20/20 20/20 Homozygote mt
Table 2: Genotypes of the animals with an excised vector. Mouse 
A in one chromosome, Mouse B in both chromosomes.
mouse 1.2H D6NC3 D6Mit236 D6NC5
A cf/n cf/cf (20/20) cf/cf (20/20) cf/cf (20/20)
B n/n cf/cf (20/20) cf/cf (20/20) cf/cf (20/20)
Table 3: Primer sequences used for the amplification of the long range products.
Primer name Primer sequence 5'-3' Expected size Allele
Cftr-5012 CCT TCC ATG TAC CCC TCC TCA CTT 5012 bp Wild type
CCC GGC ATA ATC CAA GAA AAT TG
Cftr-5198 TGT GGG AAA TCC TGT GCT GAA A 5198 bp mutant
CTT CCG GCT CGT ATG TTG TGT T
Cftr-3736 CAC ACA ACA TAC GAG CCG GAA G 3736 bp mutant
TTT ATT GCC GAT CCC CTC AGA A
Cftr-3473 CTC GTG CTT TAC GGT ATC GCC 3473 bp mutant
TGC TGT AGT TGG CAA GCT TTG APage 5 of 12
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BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/6Long range PCRFigure 3
Long range PCR. a) Map position of the long range PCR product corresponding to the 5012 bp wild type sequence. b) Map 
position of the three long range products corresponding to the mutant allele. c) Representative agarose gel (1%) indicating the 
expected PCR products for all four primer sets.
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BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/6In order to corroborate this suspicion that the vector had
been excised in both the heterozygous and homozygous
state a long range PCR protocol was established that
encompasses the targeted region in intron 9 and exon 10
for both wild type and mutant chromosomes. Four sets of
primers were designed (Table 3), one product of 5012 bp
corresponding to wild type Cftr allele and three primer
sets corresponding to the mutant allele with the inserted
sequence (Figure 3). Mouse B was positive only for the
5012 bp product confirming the absence of the pIV3.5H
vector on both chromosomes, whereas mouse A was pos-
itive for all four products indicative of a CF heterozygous
mouse. In mouse B the inserted vector had been excised
from both chromosomes, and in mouse A in one
chromosome.
Primer walking
The sequence integrity of the complete homologous tar-
geted region was checked by primer walking. Fifteen sets
of primers were designed from Cftr exon 9 to intron 10
(Table 4, Figure 4), and all products of the mutant mice
were compared against the BALB/c wild type control. PCR
products suspicious for differential migration behaviour
on 2.5% agarose compared to those obtained from the
wild type BALB/c DNA were sequenced. For all five
selected PCR products including NC13 which corre-
sponds to the area in Cftr intron 9 where the vector was
introduced via homologous recombination [12] the
sequence was found to be 100% wild type Cftr with no
insertional vector (pIV3.5H) sequence retention. Small
sequence alterations were observed when compared to the
AF162137 database C57BL/6 derived sequence, most
likely representing SNPs between the mouse strains used
for the generation of the CftrTgH(neoim)Hgu mouse model
(MF/1, 129P2) and the C57BL/6 mouse strain. In sum-
mary, since sequencing by primer walking revealed nei-
ther any loss of wild type Cftr sequence nor retention of
vector sequence, we conclude that in the two mice the
pIV3.5H insertion vector had been completely removed
(by the base) from the disrupted Cftr locus.
Table 4: Primer sequences used for primer walking spanning the entire region from Cftr exon 9 to Cftr intron 10. Location based on the 
Genome Database Cftr sequence (AF 162137)
Primer name Location Sequence 5'-3' Product Size
NCEx9I9-A 197720- 197742 TTT GGG GAA TTA CTG GAG AAA G 419 bp
NCEx9I9-B 198138- 198117 AGC TCG CTG ATA GGT TAT CCA
NC10-A 198002-198023 CCC CTC CTC ACT TCC ATT AAA 400 bp
NC10-B 198402-198381 TTT AAG GCT CAG GGC TAA TTG
NC11-A 198376- 198396 TTC CAC AAT TAG CCC TGA GC 649 bp
NC11-B 199024- 199001 TGA AGG AAA TCA TTA CTG AAG CA
NC12-A 199001- 199024 TGC TTC AGT AAT GAT TTC CTT CA 550 bp
NC12-B 199551- 199531 TAT GGA TCC CCA CAG CAA GT
NC13-A 199394- 199414 CTC AGG GAT TGT CAC GGT TT 563 bp
NC13-B 199966- 199946 GCT TTG ATC TCT GGG AGC AC
NC14-A 199741- 199763 GAT CAC AGG AGC CTA GCA TAG A 550 bp
NC14-B 200290- 200268 TTC ACT TTA CAT CCT GGC TTC A
NC15-A 200122- 200142 ACT GGG AGA GGA TGC AAA AA 575 bp
NC15-B 200696- 200676 CCC AGT GTG AGA AGA TGC AC
NC16-A 200572- 200592 TGC TCC CAG AAA TCT TCA CC 582 bp
NC16-B 201153- 201133 AGT TGT CAG AAG GGA ACC CA
NC17-A 201134- 201154 TGG GTT CCC TTC TGA CAA CT 582 bp
NC17-B 201715- 201695 TTA GGT CCC CGT GCT TAC AC
NC19-A 201739- 201759 TAG GTG GAT CCA TAA CCC CA 480 bp
NC19-B 202219- 202199 GGA CAG AGA AGC AGG AGT GG
NC20-A 202199- 202219 CCA CTC CTG CTT CTC TGT CC 487 bp
NC20-B 202686- 202666 AAA GAA GAG CGA GCC CCT AC
NCI9Ex10-A 202593- 202612 CCA TAG CCC AAG AGC TTT CA 413 bp
NCI9Ex10-B 203007-202987 GTA CCC GGC ATA ATC CAA GA
NCEx10I10-A 202986-203006 TTC TTG GAT TAT GCC GGG TA 403 bp
NCEx10I10-B 203387-203367 TTT CCA GTT GGG GGT ACA CT
NC21-A 203296- 203316 GGG CTT CAA GGC CTA ATT CT 479 bp
NC21-B 203775- 203755 ATG TGA TCC AGA CTG GCC TA
NC22-A 203654- 203674 ATG CAT GGG GTG TGG TAC TT 625 bp
NC22-B 204277- 204255 TCC AAT GAT CTA CCT GTG TCC APage 7 of 12
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Genetic analysis of complex human diseases such as cystic
fibrosis has been successfully supported by the use of var-
ious mouse models. In order to dissect the role of the dif-
ferent induced mutations to the murine Cftr gene used
from the genetic background, the genomic section carry-
ing the mutation is transferred by repeated backcross
cycles to another defined inbred background (introgress-
ing), creating congenic strains. We have generated three
congenic CftrTgH(neoim)Hgu strains by crossing the mutant
animals to the three inbred backgrounds BALB/c, C57BL/
6, DBA/2J. In each generation germline transmission of
the disrupted Cftr locus was monitored using Southern
Blot Hybridisation [12]. In order to observe germline
transmission of the disrupted Cftr locus we have estab-
lished an alternative 'high-throughput' genotyping proto-
col using Cftr intragenic microsatellites, which enabled us
to identify animals carrying the insertional mutation
based upon the different haplotypic backgrounds of the
three inbred strains and the mutant CF/3- CftrTgH(neoim)Hgu
inbred line at the Cftr locus.
The present study is to the best of our knowledge, the first
deliberate search for polymorphic intragenic Cftr markers
for the establishment of Cftr haplotypic backgrounds of
wild type inbred mouse strains. It has been shown that
some of the more common polymorphisms in the human
CFTR gene have consequences at the functional level. The
presence of an allele at a particular locus can determine
the proportion of transcripts from which functional CFTR
protein can be translated affecting CFTR maturation and
the net chloride transport activity of CFTR-expressing cells
[15]. Although it remains to be proven whether intragenic
changes can account for phenotypic variability in disease
expression among mice with different Cftr background
carrying the same mutation, it can not be excluded that
they may have a potential effect on the severity of the CF
phenotype by several mechanisms.
In our study the determination of the Cftr haplotypic
backgroung provided a useful tool for the identification of
mutant animals. Using this protocol we have successfully
verified the genotype of 55 out of 57 animals bred to the
three inbred backgrounds, previously genotyped by
Southern blot hybridisation using the 1.2H probe.
Excision
In two separate cases (mouse A and mouse B) the South-
ern insertional mutation genotype could not be verified
with the three intragenic microsatellites. A heterozygous
mouse A and a homozygous wild type mouse B, as indi-
cated via Southern blot hybridisation were homozygous
for the intragenic microsatellite genotype linked to the
disrupted Cftr locus (CF/3- CftrTgH(neoim)Hgu background).
Further investigation on these two mice (see Results sec-
tion) revealed that the outcome of both genotyping
methods was correct, supporting the hypothesis of the
event of pIV3.5H insertional vector being excised from the
mutated Cftr locus, on both chromosomes in mouse B
and in one chromosome in mouse A. Primer walking
revealed that the 7.3 kb vector has been excised precisely
from the mutated Cftr locus without causing any sequence
alteration in the Cftr gene. Both mouse A and mouse B are
littermates of the same two parental animals heterozygous
for the mutation as indicated by Southern blot and Cftr
intragenic microsatellite genotyping. Further investiga-
Primer walkingFigure 4
Primer walking. Straight lines represent the fragment amplified by each primer set, overlapping sequences are represented 
by boxes.
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same litter from these two parental animals revealed that
three further animals had inconsistent genotyping with
two animals (C and D) resembling littermate A and
mouse E resembling littermate B, whereas four animals (F,
G, H, I) were homozygous CF. The above supports the
hypothesis that the excision event had occurred during
gametogenesis in both the male and the female parental
germlines.
The mechanism responsible for this excision repair event
must be independent from the mismatch repair (MMR)
and nucleotide exchange repair (NER) pathways, since the
size of the vector overexceeds the maximum of mis-
matched nucleotides they can efficiently repair [16-18].
The mechanism involved in the excision of the vector and
the subsequent restoration of the mutated Cftr locus to
wildtype can not be gene conversion as seen in other
organisms [19,20], because the genetic background is
conserved. If the mechanism involved large loop repair by
incorporating the vector in a heteroduplex there must be
a novel mechanism, which is independent of gene conver-
sion-restoration events.
O type sequence insertion vectors [21] such as the
pIV3.5H, contain an uninterrupted stretch of target-
homology with exonic sequence that results in duplica-
tion of a large stretch of sequence flanking the heterolo-
gous sequence of the plasmid resembling transposable
elements, flanked by large direct repeats. Reports [22] on
precise excision events of transposable elements without
leaving a footprint involve an alternative mechanism of
repair rather than gene conversion which is dependent on
length of the repeat flanking the element. It is therefore
highly likely that a similar mechanism is responsible for
the precise excision of the pIV3.5H insertion vector.
This is the first report where an O type vector used in order
to generate insertion mutagenesis in the mouse, has been
excised. Such events probably remained unnoticed
because most of the methods used in order to identify ani-
mals which carry the targeted locus base their detection
almost exclusively on the presence or absence of the
inserted sequence, without taking into consideration the
genetic background of the mouse strain adjacent to the
insertion, therefore an excision event would not be easily
identified. Unlike Southern hybridisation the genotyping
protocol that we propose in this study does not indicate
the presence of the insertion vector directly based on the
presence of its sequence in the disrupted locus, but man-
ages to discriminate insertional mutant animals from the
haplotypes associated with the disrupted locus in the Cftr
gene. In our study the haplotypes obtained from the three
informative intragenic Cftr microsatellites were differen-
tial to the haplotypes associated with the insertional
mutant mouse, allowing identification of excision events.
Conclusion
Microsatellite markers spanning the mouse genome have
been used for the enhancement of congenic breeding,
reducing the time to 18–24 months (speed congenics)
from an initial 2.5–3 year period [23,24]. Here we
describe the use of Cftr intagenic markers which allowed
fast and efficient identification of the differential locus
during backcrossing. Moreover, this method provided a
useful tool whereby unexpected events such as vector exci-
sion from the disrupted Cftr locus have been revealed pos-
ing questions for the stability of insertional mutants
generated by this strategy. Furthermore, given our obser-
vations that different haplotypic backgrounds were found
between the inbred strains raises questions on whether
alleles at polymorphic loci can affect cftr at the transcript
and/or protein level and whether it would be beneficial to
study Cftr induced mutations on the respective haplotypic
background of the individual strains.
Methods
Experimental animals
All experiments were approved by the local Institutional
Animal Care and Research Advisory Committee as well as
by the local government. CftrTgH(neoim)Hgu mice were bred
under specified pathogen-free conditions in the isolator
unit of the Central Laboratory Animal Facility of the Han-
nover Medical School. Mice were kept in a flexible film
Table 5: Mouse A and B littermate genotypes.
mouse 1.2H D6NC3 D6Mit236 D6NC5
C cf/n cf/cf (20/20) cf/cf (20/20) cf/cf (20/20)
D cf/n cf/cf (20/20) cf/cf (20/20) cf/cf (20/20)
E n/n cf/cf (20/20) cf/cf (20/20) cf/cf (20/20)
F cf/cf cf/cf (20/20) cf/cf (20/20) cf/cf (20/20)
G cf/cf cf/cf (20/20) cf/cf (20/20) cf/cf (20/20)
H cf/cf cf/cf (20/20) cf/cf (20/20) cf/cf (20/20)
I cf/cf cf/cf (20/20) cf/cf (20/20) cf/cf (20/20)Page 9 of 12
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tained at 20–24°C with 40–50% relative humidity. Ani-
mals were fed an irradiated (50 kGy) standard chow
(Altromin 1314) and autoclaved water (134°C for 50
min) ad libitum.
Generation of inbred CftrTgH(neoim)Hgu mutant mice
For the establishment of the inbred CF/1-CftrTgH(neoim)Hgu
and CF/3- CftrTgH(neoim)Hgu population, one pair with diver-
gent genetic background (generation F4) of one
homozygous male and one homozygous female was
obtained from the MRC Human Genetics Unit, Edin-
burgh. Two separate litters were obtained and two ani-
mals of each litter became the starting population for the
establishment of the two individual inbred
CftrTgH(neoim)Hgu lines CF/1- CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu which were generated by brother-sister
mating for now more than 26 generations.
Generation of congenic CftrTgH(neoim)Hgu mutant mice
CF/3- CftrTgH(neoim)Hgu mice served as donors for the devel-
opment of the three congenic strains C57BL/6, BALB/c
and DBA/2J, with selection for CftrTgH(neoim)Hgu for 10 gen-
erations. Genotyping of the insertion mutation was con-
ducted by Southern analysis of XbaI/SalI restricted
genomic DNA from spleen [12].
DNA purification
High molecular weight DNA was isolated from 0.15 g
spleen tissue, either fresh or thawed on ice after storage at
-20°C based on the protocol by Gross-Bellard et al. [25].
Southern blot genotyping
Heterozygous and homozygous CftrTgH(neoim)Hgu animals
were identified in each backcross generation via Southern
Blot Hybridization of XbaI/SalI genomic digests, using the
1.2H probe located in the Cftr intron 10, after double
digestion with XbaI-SalI (Figure 1). There are no SalI sites
in this region of the Cftr gene, but the targeting vector
pIV3.5H carries a unique SalI site immediately 3' to the
neo gene. Animals carrying the mutation were identified
by the novel 5 kb XbaI-SalI fragment hybridizing to 1.2H.
Microsatellite selection
The sequence available in the Genome Database
(AF162137) was used for manual selection of dinucle-
otide repeat units spanning the murine Cftr gene. Five
microsatellite markers were identified in Cftr intron 1
(D6NC3), intron 2 (D6NC4), intron 8 (D6NC2), intron
10 (D6NC1) and intron 18 (D6NC5). Flanking primers
designed with the oligonucleotide designing program
Primer 3 http://frodo.wi.mit.edu are listed in Table 6.
Genotyping of microsatellites
Microsatellite markers were genotyped in 96 well plates
purchased from Greiner, Frickenhausen, pre-coated with
50 ng DNA per well in a Hybaid Thermocycler (Hybaid,
Teddington) with a heated lid. One of the two primers per
microsatellite was 5'-terminal biotinylated. PCR was per-
formed in a total volume of 30 µl, without oil overlay,
using InViTaq polymerase (InViTek, Berlin). After PCR an
8 µl aliquot was transferred to a multiwell plate and
allowed to dry overnight at 37°C, dissolved in 10 µl load-
ing buffer (0.2% w/v xylenecyanol and bromphenolblue
in formamide) and denatured for 5 min at 95°C. The PCR
products were separated by direct blotting electrophoresis
(GATC 1500, MWG Biotech, Ebersberg, Germany) on a
denaturing acrylamide gel (4% acrylamide/N,N'-methyl-
enebisacrylamide 29:1 containing 6 M urea in 0.9 M Tris-
0.9 M boric acid-0.02 M EDTA buffer) and simultaneously
transferred to a Hybond N+membrane (Amersham). Sig-
nals were visualised by blocking the membrane in
1.5%(w/v) of blocking reagent in Buffer 1 (100 mM Tris-
HCl, 150 mM NaCl, pH 7.5), followed by incubation in
diluted solution of anti-biotin alkaline phosphatase con-
jugate in Buffer 1. The membrane was further washed
three times with 1% Triton X-100 in Buffer 1 and equili-
brated for 15 min in assay buffer (100 mM Tris-HCl, 100
mM NaCl, 50 mM MgCl2, pH 9.5). The membrane was
covered for 5 min with reaction buffer containing 10%(v/
v) Sapphire II (Tropix) and 60 µl CDPstar (Tropix)in 50
ml assay buffer, followed by rinsing with a solution con-
taining 1% v/v Sapphire II and 6 µl CDPstar in 50 ml assay
buffer. Signals were exposed to Kodak XA-R films and the
exposition time varied from 10 min to 45 min. Evaluation
of results was performed as described by Mekus et al. [26].
Long-range PCR
150 ng of DNA template was each amplified in 12 differ-
ent premixes using the Failsafe ™ PCR System (EPICEN-
Table 6: Primer sequences used for the amplification of the 
intragenic Cftr microsatellites. The forward primer is 
5'biotinylated.
Primer name Primer sequence 5'-3'
D6NC1-A BIOTIN-TGC TTG AGC TAT CCA TTC TGA
D6NC1-B TAC CCA ATG TTG CCA TCT GA
D6NC2-A BIOTIN-TTG GAA GTG AGG ATT GCC TT
D6NC2-B TGC CTC AGT CTC ATA TTA TTG C
D6NC3-A BIOTIN-TCT CAG CCT GTC TTC CTC TCA
D6NC3-B TCC TCC CAA AAC AGC TTC AC
D6NC4-A BIOTIN-GAG TTG GAG AGG CTG TTT GG
D6NC4-B TGT GCC AGG ACA CTG TGA CT
D6NC5-A BIOTIN-TTC AAA TGA CCA AAA TCC CC
D6NC5-B TGG CAA ATT TTC AAC AAC AAAPage 10 of 12
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using primers described in Table 3 separated by 1% agar-
ose gel electrophoresis and visualised under UV illumina-
tion, the optimal reaction mixture was thereafter chosen
for further amplifications (Figure 3).
Neo PCR
Cftr intron 9-pIV3.5H vector and neo -Cftr intron 9 span-
ning primers, (Table 7) were amplified using PCR of 50 ng
DNA template in a total volume of 30 µl with InViTaq
polymerase (InViTek, Berlin) in 96 well plates. Full-length
and SalI restricted PCR products were separated by 2.5%
agarose gel electrophoresis.
Excision scanning by primer walking
Based on the Genome Database Cftr sequence
(AF162137) 15 overlapping pairs (Table 4) of primers
spanning the entire region from exon 9 to intron 10 of the
murine Cftr gene were designed, using the Primer 3 oligo
design program http://frodo.wi.mit.edu. PCR reactions
were performed on DNA with inconsistent Southern and
microsatellite insertional mutation genotypes and con-
trols in 96 well plates precoated with 50 ng of DNA
template using InViTaq polymerase (InViTek, Berlin). Full
length products were separated on 2.5% agarose gels and
visualised under UV illumination.
Sequencing
Following PCR amplification the chosen PCR products
were sequenced by Qiagen GmbH.
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